Citigroup’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-33,672
| Closed | -$3.27M | – | 5296 |
|
|
2019
Q3 | $3.27M | Sell |
33,672
-105,346
| -76% | -$10.2M | ﹤0.01% | 1293 |
|
|
2019
Q2 | $14.2M | Sell |
139,018
-82,396
| -37% | -$8.44M | 0.01% | 675 |
|
|
2019
Q1 | $25.2M | Buy |
221,414
+137,183
| +163% | +$15.6M | 0.02% | 401 |
|
|
2018
Q4 | $3.3M | Buy |
84,231
+4,630
| +6% | +$181K | ﹤0.01% | 1249 |
|
|
2018
Q3 | $4.34M | Buy |
79,601
+34,038
| +75% | +$1.86M | ﹤0.01% | 1072 |
|
|
2018
Q2 | $3.77M | Sell |
45,563
-12,815
| -22% | -$1.06M | ﹤0.01% | 1153 |
|
|
2018
Q1 | $3.89M | Sell |
58,378
-5,321
| -8% | -$354K | ﹤0.01% | 1097 |
|
|
2017
Q4 | $3.28M | Buy |
63,699
+27,307
| +75% | +$1.4M | ﹤0.01% | 1190 |
|
|
2017
Q3 | $3.25M | Sell |
36,392
-37,559
| -51% | -$3.35M | ﹤0.01% | 1187 |
|
|
2017
Q2 | $4.42M | Buy |
73,951
+47,347
| +178% | +$2.83M | ﹤0.01% | 1011 |
|
|
2017
Q1 | $1.42M | Sell |
26,604
-73,133
| -73% | -$3.9M | ﹤0.01% | 1658 |
|
|
2016
Q4 | $4.98M | Buy |
99,737
+88,420
| +781% | +$4.41M | ﹤0.01% | 1046 |
|
|
2016
Q3 | $680K | Buy |
11,317
+3,617
| +47% | +$217K | ﹤0.01% | 2222 |
|
|
2016
Q2 | $394K | Sell |
7,700
-6,273
| -45% | -$321K | ﹤0.01% | 2392 |
|
|
2016
Q1 | $413K | Buy |
13,973
+4,820
| +53% | +$142K | ﹤0.01% | 2863 |
|
|
2015
Q4 | $415K | Sell |
9,153
-9,525
| -51% | -$432K | ﹤0.01% | 2497 |
|
|
2015
Q3 | $779K | Buy |
18,678
+18,001
| +2,659% | +$751K | ﹤0.01% | 1902 |
|
|
2015
Q2 | $40K | Sell |
677
-1,958
| -74% | -$116K | ﹤0.01% | 3886 |
|
|
2015
Q1 | $205K | Buy |
+2,635
| New | +$205K | ﹤0.01% | 2932 |
|